• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻和口腔黏膜途径预防呼吸道感染的进展:与抗击新冠疫情的相关性

Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.

作者信息

Ivanova Nadezhda, Sotirova Yoana, Gavrailov Georgi, Nikolova Krastena, Andonova Velichka

机构信息

Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 55 Marin Drinov Str., 9000 Varna, Bulgaria.

Department of Physics and Biophysics, Faculty of Pharmacy, Medical University of Varna, 55 Marin Drinov Str., 9000 Varna, Bulgaria.

出版信息

Pharmaceutics. 2022 Feb 27;14(3):530. doi: 10.3390/pharmaceutics14030530.

DOI:10.3390/pharmaceutics14030530
PMID:35335905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953301/
Abstract

In this time of COVID-19 pandemic, the strategies for prevention of the infection are a primary concern. Looking more globally on the subject and acknowledging the high degree of misuse of protective face masks from the population, we focused this review on alternative pharmaceutical developments eligible for self-defense against respiratory infections. In particular, the attention herein is directed to the nasal and oromucosal formulations intended to boost the local immunity, neutralize or mechanically "trap" the pathogens at the site of entry (nose or mouth). The current work presents a critical review of the contemporary methods of immune- and chemoprophylaxis and their suitability and applicability in topical mucosal dosage forms for SARS-CoV-2 prophylaxis.

摘要

在新冠疫情期间,感染预防策略是首要关注点。从更宏观的角度看待这个问题,并认识到民众对防护口罩的滥用程度很高,我们将本次综述聚焦于适用于自我防御呼吸道感染的替代药物研发。特别是,本文重点关注旨在增强局部免疫力、在病原体进入部位(鼻子或口腔)中和或机械“捕获”病原体的鼻腔和口腔黏膜制剂。当前的工作对免疫预防和化学预防的当代方法及其在用于预防新冠病毒的局部黏膜剂型中的适用性和实用性进行了批判性综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa2/8953301/aefa384f319e/pharmaceutics-14-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa2/8953301/d3b1611f38d6/pharmaceutics-14-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa2/8953301/aefa384f319e/pharmaceutics-14-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa2/8953301/d3b1611f38d6/pharmaceutics-14-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa2/8953301/aefa384f319e/pharmaceutics-14-00530-g002.jpg

相似文献

1
Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.经鼻和口腔黏膜途径预防呼吸道感染的进展:与抗击新冠疫情的相关性
Pharmaceutics. 2022 Feb 27;14(3):530. doi: 10.3390/pharmaceutics14030530.
2
Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community.探索抗病毒鼻喷雾剂在社区新发呼吸道感染控制中的作用。
Infect Dis Ther. 2022 Dec;11(6):2287-2296. doi: 10.1007/s40121-022-00710-z. Epub 2022 Oct 30.
3
Nasal sprays for treating COVID-19: a scientific note.用于治疗 COVID-19 的鼻腔喷雾剂:一份科学说明。
Pharmacol Rep. 2023 Apr;75(2):249-265. doi: 10.1007/s43440-023-00463-7. Epub 2023 Feb 27.
4
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
5
Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.羟丙甲纤维素鼻喷剂能有效抑制 SARS-CoV-2 体外感染和传播。
Viruses. 2021 Nov 23;13(12):2345. doi: 10.3390/v13122345.
6
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.含卡拉胶的非处方鼻腔和口腔喷雾剂可抑制 SARS-CoV-2 对气道上皮培养物的感染。
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L750-L756. doi: 10.1152/ajplung.00552.2020. Epub 2021 Feb 9.
7
Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.基于益生菌的疫苗可能为预防新冠急性呼吸道疾病提供有效保护。
Vaccines (Basel). 2021 May 6;9(5):466. doi: 10.3390/vaccines9050466.
8
Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity.黏膜疫苗对抗 SARS-CoV-2 的现状:对保护性免疫的希望。
Expert Opin Biol Ther. 2023 Feb;23(2):207-222. doi: 10.1080/14712598.2022.2156284. Epub 2023 Jan 11.
9
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗:黏膜疫苗接种与局部免疫的优势
Vaccines (Basel). 2024 Jul 18;12(7):795. doi: 10.3390/vaccines12070795.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

引用本文的文献

1
Nasal Spray Disinfectant for Respiratory Infections Based on Functionalized Silver Nanoparticles: A Physicochemical and Docking Approach.基于功能化银纳米颗粒的呼吸道感染鼻腔喷雾消毒剂:物理化学与对接方法
Nanomaterials (Basel). 2025 Mar 31;15(7):533. doi: 10.3390/nano15070533.
2
Novel Oronasal Drainage for Long COVID: Proposed Mechanisms-Case Report.新型口鼻引流治疗新冠后综合征:提出的机制——病例报告
Viruses. 2025 Jan 31;17(2):210. doi: 10.3390/v17020210.
3
In Situ Gelling Behavior and Biopharmaceutical Characterization of Nano-Silver-Loaded Poloxamer Matrices Designed for Nasal Drug Delivery.

本文引用的文献

1
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.一氧化氮与病毒感染:抗病毒疗法及平台的最新进展
Appl Mater Today. 2021 Mar;22:100887. doi: 10.1016/j.apmt.2020.100887. Epub 2020 Dec 5.
2
Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.柑橘类水果富含用于免疫调节和潜在靶向血管紧张素转换酶2(ACE2)的类黄酮。
Nat Prod Bioprospect. 2022 Feb 14;12(1):4. doi: 10.1007/s13659-022-00325-4.
3
Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
用于鼻腔给药的载纳米银泊洛沙姆基质的原位凝胶行为及生物药剂学特性
Gels. 2024 Jun 5;10(6):385. doi: 10.3390/gels10060385.
4
Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes.COVID-19 患者鼻腔冲洗和含漱的效果:病毒载量、黏膜动力学和患者结局的多学科综述。
Front Public Health. 2023 Jun 16;11:1161881. doi: 10.3389/fpubh.2023.1161881. eCollection 2023.
5
Antimicrobial efficacy, mode of action and in vivo use of hypochlorous acid (HOCl) for prevention or therapeutic support of infections.次氯酸(HOCl)在预防或治疗感染方面的抗菌效力、作用方式及体内应用
GMS Hyg Infect Control. 2023 Mar 27;18:Doc07. doi: 10.3205/dgkh000433. eCollection 2023.
6
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics.基于蛋白质结构的计算机辅助药物发现方法:针对 COVID-19 治疗的指导。
Mol Aspects Med. 2023 Jun;91:101151. doi: 10.1016/j.mam.2022.101151. Epub 2022 Oct 28.
羟丙甲纤维素鼻喷剂能有效抑制 SARS-CoV-2 体外感染和传播。
Viruses. 2021 Nov 23;13(12):2345. doi: 10.3390/v13122345.
4
In Vitro Ciliotoxicity and Cytotoxicity Testing of Repeated Chronic Exposure to Topical Nasal Formulations for Safety Studies.用于安全性研究的局部鼻腔制剂重复慢性暴露的体外纤毛毒性和细胞毒性测试
Pharmaceutics. 2021 Oct 20;13(11):1750. doi: 10.3390/pharmaceutics13111750.
5
Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.iota-卡拉胶和木糖醇可抑制 Vero 细胞培养中的 SARS-CoV-2。
PLoS One. 2021 Nov 19;16(11):e0259943. doi: 10.1371/journal.pone.0259943. eCollection 2021.
6
Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.评估口腔伴有根尖周病变的 SARS-CoV-2 病毒载量。
BMC Oral Health. 2021 Nov 8;21(1):567. doi: 10.1186/s12903-021-01921-5.
7
Can the Nasal Cavity Help Tackle COVID-19?鼻腔能帮助应对新冠病毒吗?
Pharmaceutics. 2021 Oct 3;13(10):1612. doi: 10.3390/pharmaceutics13101612.
8
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence.乳铁蛋白在 COVID-19 管理中的抗病毒治疗作用:初步证据。
Int J Environ Res Public Health. 2021 Oct 19;18(20):10985. doi: 10.3390/ijerph182010985.
9
In vitro antiviral activity of stabilized chlorine dioxide containing oral care products.含稳定二氧化氯的口腔护理产品的体外抗病毒活性。
Oral Dis. 2023 Apr;29(3):1333-1340. doi: 10.1111/odi.14044. Epub 2021 Oct 25.
10
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease.含ι-角叉菜胶的鼻喷雾剂在专门护理新冠肺炎患者的医院工作人员暴露后预防新冠病毒病中的疗效
Int J Gen Med. 2021 Oct 1;14:6277-6286. doi: 10.2147/IJGM.S328486. eCollection 2021.